Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Manufacturing Sites — ex-Sandoz by Year
Novartis Manufacturing Sites — ex-Sandoz: 31 in FY2025, down 6.1% from a year earlier.
Latest, FY2025
31
Period ended Dec 31, 2025
Change on a year earlier
-6.1%
33 in FY2024
History
3 years
Since FY2023
Sources
3
Documents cited below
Where the FY2025 figure comes from
“Our Operations organizational unit manages the production, quality, and supply chain of our products through a network of 31 manufacturing sites, as well as through external suppliers, and warehouse and distribution centers. In addition, our Operations organizational unit also manages non-production real estate owned or leased by Novartis around the world.”
Source: Novartis Form 20-F (0001114448-26-000004) ↗
Operations manufacturing network (excluding Sandoz); detailed area of 12 key manufacturing & R&D sites (m²) in sub-rows
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Manufacturing Sites — ex-Sandoz | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 31 | -6.1% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2024 | Dec 31, 2024 | 33 | 0.0% | Novartis Form 20-F (0001370368-25-000004) ↗ |
| FY2023 | Dec 31, 2023 | 33 | – | Novartis Form 20-F (0001370368-24-000004) ↗ |
Breakdown
What makes up manufacturing Sites — ex-Sandoz
- Global Headquarters & R&D Basel — St. Johann, Switzerland (m²)481,448 · FY2025
- Biologics & Nucleic Acid Complex Kundl & Schaftenau, Austria (m²)283,017 · FY2025
- Biomedical Research Center Cambridge, Massachusetts, US (m²)167,225 · FY2025
- Biologics & Drug Substance Complex Menges, Slovenia (m²)166,591 · FY2025
- US Commercial Headquarters & R&D in East Hanover, New Jersey (m²)123,751 · FY2025
- Shanghai Headquarters & R&D Institute, China (m²)105,614 · FY2025
- Sterile Injectables & Tablets Facility Stein, Switzerland (m²)64,700 · FY2025
- Biologics Facility Huningue, France (m²)41,000 · FY2025
- Zolgensma Gene Therapy Facility in Durham, North Carolina, US (m²)15,794 · FY2025
- Leqvio siRNA Drug Substance Facility in Schweizerhalle, Switzerland (m²)8,880 · FY2025
- Pluvicto & Lutathera Radioligand Therapy Facility in Indianapolis, US (m²)8,230 · FY2025
- Pluvicto & Lutathera Radioligand Therapy Facility in Ivrea, Italy (m²)4,300 · FY2025
Cite this data
StockData. (2026). Novartis Manufacturing Sites — ex-Sandoz, annual FY2023–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/mfg-sites-network
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.